Aeglea BioTherapeutics
Drugs for the treatment of tumors the company was incorporated in 2013 and is based in texas.
Launch date
Employees
Market cap
$1.5b
Enterprise valuation
$1.1b (Public information from Sep 2024)
Share price
$30.4 AGLE
Austin Texas (HQ)
Authorizing premium user...